|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-05
|
$347,563
|
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral Mechanisms
|
5R01CA181064-05
|
$593,588
|
|
MUSTIAN, KAREN
|
UNIVERSITY OF ROCHESTER
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors
|
5R01CA178932-05
|
$402,550
|
|
O'SHEA, CLODAGH
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Viral Modulation of Genetic Stability
|
5R01CA097093-15
|
$399,000
|
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
VEGF signaling in Mammary Tumorigenesis
|
5R01CA168464-07
|
$397,813
|
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
|
5R01CA174976-05
|
$351,104
|
|
MAITY, AMIT
|
UNIVERSITY OF PENNSYLVANIA
|
|
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)
|
5U01AI035041-26
|
$210,000
|
|
RINALDO, CHARLES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
5R01CA181633-05
|
$332,000
|
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations
|
1R01CA228589-01
|
$601,819
|
|
SETIAWAN, VERONICA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Understanding optimal delivery systems for cancer care
|
5R01CA174768-05
|
$380,646
|
|
MILLER, DAVID
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
UAB Cancer Prevention and Control Training Program (T32)
|
2T32CA047888-29
|
$288,255
|
|
DEMARK-WAHNEFRIED, WENDY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
|
5R01CA200574-03
|
$359,138
|
|
ZHANG, LIANGFANG
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
TSPO-PET to Image Pancreatic Cancer and High-Risk Precursor Lesions
|
5F30CA196087-03
|
$49,524
|
|
WATCHMAKER, JENNIFER
|
VANDERBILT UNIVERSITY
|
|
Treating cognitive impairments in cancer patients via systematic light exposure
|
5K07CA184145-05
|
$166,167
|
|
WU, LISA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Transmembrane Proteins Involved in Human Tumor Expansion
|
5R01CA105412-14
|
$423,800
|
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
Translational Research of Biobehavioral Mechanisms in Cancer Control
|
5K07CA188237-04
|
$153,108
|
|
LAMKIN, DONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Translational regulation of the breast cancer stem cell by eIF4G1
|
5R01CA178509-04
|
$405,600
|
|
SCHNEIDER, ROBERT
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Translational Genomics and Precision Medicine in Cancer Training Program
|
1T32CA217789-01A1
|
$236,106
|
|
KILLARY, ANN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Training in Pediatric Cancer Survivorship Outcomes and Interventions
|
1T32CA225590-01
|
$244,999
|
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Training in Cancer Biology
|
5T32CA009547-33
|
$535,845
|
|
SCHREIBER, ROBERT
|
WASHINGTON UNIVERSITY
|
|
Training Grant in Tumor Biology
|
5T32CA009686-22
|
$598,069
|
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
|
Towards The Chemotherapy-Free Treatment of Follicular Lymphoma
|
5R01CA183876-05
|
$475,801
|
|
WENDEL, HANS-GUIDO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Topology of Cancer Evolution and Heterogeneity
|
5U54CA193313-04
|
$2,030,348
|
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
To enhance breast cancer survivorship of Asian Americans
|
5R01CA203719-03
|
$576,193
|
|
IM, EUN-OK
|
DUKE UNIVERSITY
|
|
TMAO, the Gut Microbiome, and Colorectal Cancer Risk in the Multiethnic Cohort
|
5R01CA204368-03
|
$319,624
|
|
LIM, UNHEE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Tissue Specific Regulation of Diabetes-Associated Cancer Growth
|
5R01CA177771-05
|
$328,888
|
|
STENINA, OLGA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
5R01CA115483-14
|
$345,281
|
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Therapeutic and Sustained Cytokine Delivery at the Tumor Site Using Engineered Mononuclear Cells
|
5F30CA203325-03
|
$38,249
|
|
DONAHUE, PATRICK
|
NORTHWESTERN UNIVERSITY
|
|
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci
|
5R01CA187090-05
|
$322,663
|
|
YI, CHUNLING
|
GEORGETOWN UNIVERSITY
|
|
The Tumor Suppressor Role of SMARCA4 in SCCOHT
|
5R01CA195670-04
|
$714,783
|
|
WEISSMAN, BERNARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia
|
5R01CA188561-05
|
$348,844
|
|
OPAVSKY, RENE
|
UNIVERSITY OF FLORIDA
|
|
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
|
5U01CA207532-02
|
$349,332
|
|
DYKHUIZEN, EMILY
|
PURDUE UNIVERSITY
|
|
The role of wild-type KRAS in the context of tumor profession and metastasis
|
5R01CA178445-04
|
$450,563
|
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of the LZTR1 ubiquitin ligase in stem cells and cancer
|
5R01CA190891-04
|
$383,079
|
|
IAVARONE, ANTONIO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of short-form Ron (sfRon) kinase in the pathogenesis of high-grade serous ovarian cancer
|
5K22CA207602-02
|
$159,705
|
|
BIENIASZ, MAGDALENA
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
|
The Role of post-translational activation of Myc in pancreatic cancer
|
5R01CA196228-04
|
$390,191
|
|
SEARS, ROSALIE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The role of MDM2-MTBP axis in cancer metastasis
|
5R01CA174735-05
|
$313,325
|
|
IWAKUMA, TOMOO
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
The role of MCM8-9 in genomic instability of cancers
|
5R01CA060499-24
|
$355,500
|
|
DUTTA, ANINDYA
|
UNIVERSITY OF VIRGINIA
|
|
The role of HIF2alpha in colon carcinogenesis
|
5R01CA148828-09
|
$368,125
|
|
SHAH, YATRIK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The role of glioblastoma derived activated leukocyte cell adhesion molecule in peripheral monocyte PD-L1 induction and immunosuppression
|
5F30CA206413-03
|
$49,524
|
|
LAMANO, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of genetic susceptibility in melanoma development
|
5R01CA182890-05
|
$404,587
|
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN
|
5R01CA200263-03
|
$479,883
|
|
DOUGHERTY, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The role of EGFR as a mechanism of therapeutic resistance in gene fusion positive lung cancer.
|
5R01CA193935-03
|
$422,586
|
|
DOEBELE, ROBERT
|
UNIVERSITY OF COLORADO DENVER
|
|
The role of DDR2 in the breast cancer microenvironment
|
5F30CA200386-03
|
$49,524
|
|
VAN HOVE, SAMANTHA
|
WASHINGTON UNIVERSITY
|
|
The role of Cyclin E and Cks proteins in growth control and tumorigenesis
|
5R01CA078343-20
|
$673,750
|
|
REED, STEVEN
|
SCRIPPS RESEARCH INSTITUTE
|
|
The Role of And-1 in DNA Damage Response
|
5R01CA177898-05
|
$328,888
|
|
ZHU, WENGE
|
GEORGE WASHINGTON UNIVERSITY
|
|
The role of adipocyte/macrophage fatty acid binding protein in breast cancer deve
|
5R01CA177679-05
|
$317,792
|
|
LI, BING
|
UNIVERSITY OF LOUISVILLE
|
Total relevant funding to Alcoholism Research for this search: $612,111
|